Literature DB >> 30632884

Relationship Between Different Resistance Mechanisms and Virulence in Acinetobacter baumannii.

Paula Espinal1,2, Alix Pantel2,3, Dora Rolo1, Sara Marti4,5, Rafael López-Rojas6, Younes Smani6, Jerónimo Pachón6, Jordi Vila1, Jean-Philippe Lavigne2,3.   

Abstract

Aim: This study analyzed the virulence of several Acinetobacter baumannii strains expressing different resistance mechanisms using the Caenorhabditis elegans infection model.
Results: Strains susceptible/resistant to carbapenems (presenting class D (OXA-23, OXA-24), class B metallo-β-lactamase (MBL) (NDM-1), penicillin binding protein (PBP) altered and decreased expression of Omp 33-36 kDa) and isogenic A. baumannii strains susceptible/resistant to colistin (presenting loss of lipopolysaccharide (LPS) and pmrA mutations) were included to evaluate the virulence using the C. elegans infection model. The nematode killing assay, bacterial ingestion in worms, and bacterial lawn avoidance assay were performed with the Fer-15 mutant line. A. baumannii strains generally presented low virulence, showing no difference between carbapenem-resistant strains (expressing class D, MBLs, or altered PBP) and their isogenic susceptible strains. In contrast, the absence of the Omp 33-36 kDa protein in the knockout was associated with a decrease of virulence, and a significant difference was observed between colistin-resistant mutants and their susceptible counterpart when the mechanism of resistance was associated with the loss of LPS but not with its modification. Conclusions: Resistance to carbapenems in A. baumannii associated with the production of OXA-type or NDM-type enzymes does not seem to affect their virulence in the C. elegans infection model. In contrast, the presence of Omp 33-36 kDa, and high level resistance to colistin related with the loss of LPS, might contribute with the virulence profile in A. baumannii.

Entities:  

Keywords:  carbapenemase; impermeability; multidrug resistance; virulence

Mesh:

Substances:

Year:  2019        PMID: 30632884     DOI: 10.1089/mdr.2018.0182

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  6 in total

1.  Design of a Multi-epitope Vaccine Against Acinetobacter baumannii Using Immunoinformatics Approach.

Authors:  Maryam Touhidinia; Fatemeh Sefid; Mozhgan Bidakhavidi
Journal:  Int J Pept Res Ther       Date:  2021-08-28       Impact factor: 1.931

2.  Antibiotics Act with vB_AbaP_AGC01 Phage against Acinetobacter baumannii in Human Heat-Inactivated Plasma Blood and Galleria mellonella Models.

Authors:  Bartłomiej Grygorcewicz; Marta Roszak; Piotr Golec; Daria Śleboda-Taront; Natalia Łubowska; Martyna Górska; Joanna Jursa-Kulesza; Rafał Rakoczy; Bartosz Wojciuk; Barbara Dołęgowska
Journal:  Int J Mol Sci       Date:  2020-06-19       Impact factor: 5.923

3.  In vitro and in vivo Virulence Potential of the Emergent Species of the Acinetobacter baumannii (Ab) Group.

Authors:  Clara Cosgaya; Carlos Ratia; Marta Marí-Almirall; Laia Rubio; Paul G Higgins; Harald Seifert; Ignasi Roca; Jordi Vila
Journal:  Front Microbiol       Date:  2019-10-24       Impact factor: 5.640

4.  In Vitro and In Vivo Effect of Peptides Derived from 14-3-3 Paracoccidioides spp. Protein.

Authors:  Liliana Scorzoni; Ana Carolina Alves de Paula E Silva; Haroldo Cesar de Oliveira; Claudia Tavares Dos Santos; Junya de Lacorte Singulani; Patricia Akemi Assato; Caroline Maria Marcos; Lariane Teodoro Oliveira; Nathália Ferreira Fregonezi; Diego Conrado Pereira Rossi; Leandro Buffoni Roque da Silva; Carlos Pelleschi Taborda; Ana Marisa Fusco-Almeida; Maria José Soares Mendes-Giannini
Journal:  J Fungi (Basel)       Date:  2021-01-13

5.  Structural and Biochemical Characterization of the Flavin-Dependent Siderophore-Interacting Protein from Acinetobacter baumannii.

Authors:  Hannah Valentino; David A Korasick; Tabbetha J Bohac; Justin A Shapiro; Timothy A Wencewicz; John J Tanner; Pablo Sobrado
Journal:  ACS Omega       Date:  2021-07-06

Review 6.  Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of Acinetobacter baumannii.

Authors:  Corneliu Ovidiu Vrancianu; Irina Gheorghe; Ilda Barbu Czobor; Mariana Carmen Chifiriuc
Journal:  Microorganisms       Date:  2020-06-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.